Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Shares of Puma Biotechnology, Inc. PBYI have rallied 24% in the past three months against the industry’s decline of 9.7%. The ...

Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...

From proton therapy firsts to tumour-killing quantum dots, Tami Freeman shares her pick of this year’s healthcare innovations ...

VIR-5818 is under clinical development by Vir Biotechnology and currently in Phase II for Metastatic Colorectal Cancer.

ANS-014004 is under development for the treatment of solid tumor and non small cell lung cancer (NSCLC). The therapeutic candidate is administered through oral route as tablet formulation. It acts by ...

The modern food system is largely dependent on a limited genetic pool of crops, raising significant concerns about ...

HQH's high yield is unsustainable, relying on capital gains and potentially forcing premature sales. Read why I'm bearish on ...

Achieving biotech sovereignty will reduce dependency on foreign nations for critical products and technologies, ensuring ...

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

The lungs are a tempting place for cancer cells -- so much so that more than half of people with advanced cancer elsewh ...

Mohali, is inviting applications for its prestigious PhD program in Biotechnology, commencing in January 2025, with research ...